Advertisement

Topics

NovaDel Pharma Inc. Company Profile

12:51 EDT 30th July 2016 | BioPortfolio

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism, which may result in lower doses. Oral sprays eliminate the requirement for water or the need to swallow, potentially improving patient convenience and adherence.


News Articles [1297 Associated News Articles listed on BioPortfolio]

NovaDel Reports Resolution of Contingent Liabilities

As previously reported, NovaDel Pharma Inc. sold its ZolpiMist® assets to Amherst Pharmaceuticals, Inc. principally in exchange for the assumption of Novadel’s FDA liabilities ...

BRIEF-UK's CMA says not to refer Leo Pharma deal to buy Astellas Pharma portfolio to investigation

* Decided not to refer anticipated acquisition by Leo Pharma of the portfolio of pharma dermatological products of Astellas Pharma to phase 2 investigation Source text for Eikon: Further company cover...

VERONA PHARMA PLC - Notice of GM

Verona Pharma plc ("Verona Pharma" or the "Company") Confirmation of General Meeting Date 1 July 2016, Cardiff - Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-clas...

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

~ PCT will supply study medication for the US part of Kiadis Pharma's Phase III clinical trial with ATIR101™ ~ Regulatory News: Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amst.....

Sun Pharma gains license to SPARC's epilepsy drug

Sun Pharma and its subsidiary Sun Pharma Advanced Research Co.  -More- 

SPARC licenses Elepsia XR to Sun Pharma

Sun Pharma Advanced Research Company and India’s largest drugmaker Sun Pharma have entered into a licensing…

Moberg Pharma Divests Three Brands for $10.0 Million

Regulatory News: Moberg Pharma (STO:MOB) Moberg Pharma AB (OMX: MOB) announces that the company has entered into an agreement with Strides Pharma Inc. to divest the brands Jointflex, Fergon and Va...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

Pharma Exposure Occurs Early in Training and More Often in Rural Clinical Sites.

Hand 'stress' arthritis in young subjects: effects of Flexiqule (pharma-standard Boswellia extract). A preliminary case report.

This case report (supplement registry study) evaluated subjects with painful 'stress' arthritis of the hand mainly localized at the joints. The patients received a suggestion to follow a rehabilitatio...

Clinical Trials [59 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [692 Associated Companies listed on BioPortfolio]

Novadel Pharma, Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company that previously developed oral spray formulations of marketed pharmaceutical products. The Company has discontinued its o...

NovaDel Pharma

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments for serious diseases. The Company’s proprietary technology enabl...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers,...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "NovaDel Pharma Inc." on BioPortfolio

We have published hundreds of NovaDel Pharma Inc. news stories on BioPortfolio along with dozens of NovaDel Pharma Inc. Clinical Trials and PubMed Articles about NovaDel Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaDel Pharma Inc. Companies in our database. You can also find out about relevant NovaDel Pharma Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...


Corporate Database Quicklinks



Searches Linking to this Company Record